Huaier Sensitizes Oxaliplatin-Resistant Colorectal Cancer to Oxaliplatin by Reducing P-Glycoprotein and Inducing Nrf2/SLC7A11/GPX4-Dependent Ferroptosis
Frontiers in Bioscience-Landmark · 2026-06-15 · 31 (6)
DOI: 10.31083/fbl47735 ↗At a glance
Journal article in Frontiers in Bioscience-Landmark, published online on 2026-06-15. Written by Guizhen Wang and 5 co-authors. Institution: Department of Pathophysiology, Chengde Medical University, 067000 Chengde, Hebei, China. Major MEDLINE topics: Ferroptosis, NF-E2-Related Factor 2, Oxaliplatin, Drug Resistance, Neoplasm. 34 references. The full text is freely available (open access, CC BY 4.0). Funded by: Project Funding of Hebei Provincial Education Department, Key Discipline Construction Project of Hebei Provincial Universities.
Abstract (original language)
Background:Chemoresistance to oxaliplatin (OXA) in colorectal cancer (CRC) remains a major cause of treatment failure. This study investigated whether Huaier polysaccharide (HP) could reverse OXA resistance and explored the underlying mechanisms.Methods:Cell viability and proliferation were assessed using the Cell Counting Kit-8 (CCK-8) assay and colony formation assays, respectively. Protein expression was analyzed by Western blotting. Ferroptosis was evaluated using a lipid peroxidation probe (BDP 581/591 C11), FerroOrange, a reactive oxygen species (ROS) assay kit, and a total glutathione detection kit. Ultrastructural changes were observed using transmission electron microscopy. Nuclear and cytoplasmic protein extraction and immunofluorescence were used to examine nuclear factor erythroid 2-related factor 2 (Nrf2) expression.Results:Combined treatment with OXA and HP significantly suppressed cell viability and proliferation by inhibiting the Nrf2/solute carrier family 7 member 11 (SLC7A11)/glutathione peroxidase 4 (GPX4) pathway, thereby inducing ferroptosis. In addition, HP reduced P-glycoprotein expression and enhanced sensitivity to OXA.Conclusions:These findings demonstrate that Huaier overcomes OXA resistance in CRC cells by promoting ferroptosis through suppression of the Nrf2/SLC7A11/GPX4 signaling pathway in vitro.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Pathophysiology, Chengde Medical University, 067000 Chengde, Hebei, China.
- Department of Histology and Embryology, Chengde Medical University, 067000 Chengde, Hebei, China.
- Department of Oncology Chengde, Affiliated Hospital of Chengde Medical University, 067000 Chengde, Hebei, China.
Funding
- Project Funding of Hebei Provincial Education Department
- Key Discipline Construction Project of Hebei Provincial Universities
Cite
APA
Wang, G., Yuan, Y., Ji, H., Liu, X., Hou, Z., & Zheng, J. (2026). Huaier Sensitizes Oxaliplatin-Resistant Colorectal Cancer to Oxaliplatin by Reducing P-Glycoprotein and Inducing Nrf2/SLC7A11/GPX4-Dependent Ferroptosis. Frontiers in Bioscience-Landmark, 31(6). https://doi.org/10.31083/fbl47735
Vancouver
Wang G, Yuan Y, Ji H, Liu X, Hou Z, Zheng J. Huaier Sensitizes Oxaliplatin-Resistant Colorectal Cancer to Oxaliplatin by Reducing P-Glycoprotein and Inducing Nrf2/SLC7A11/GPX4-Dependent Ferroptosis. Frontiers in Bioscience-Landmark. 2026;31(6). doi:10.31083/fbl47735
BibTeX
@article{Wang2026,
author = {Wang, Guizhen and Yuan, Yanan and Ji, Hairu and Liu, Xin and Hou, Zhiping and Zheng, Jining},
title = {Huaier Sensitizes Oxaliplatin-Resistant Colorectal Cancer to Oxaliplatin by Reducing P-Glycoprotein and Inducing Nrf2/SLC7A11/GPX4-Dependent Ferroptosis},
journal = {Frontiers in Bioscience-Landmark},
year = {2026},
volume = {31},
number = {6},
doi = {10.31083/fbl47735}
}
EUVIMED